Diagnostic challenges in detecting coagulase-negative Staphylococcus aureus by coagulase testing

Tran Thi Cam Tien 1, Thu Quang Le Hanh 1, Nguyen Bac V.G 2,
1 Faculty of Medical Laboratory Techniques, Nguyen Tat Thanh University, Ho Chi Minh City
2 School of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City

Nội dung chính của bài viết

Tóm tắt

Background: Staphylococcus aureus is a major human pathogen whose identification in clinical laboratories often relies on the detection of coagulase activity. While rabbit plasma has long been considered the gold standard for the tube coagulase test, discrepancies in test results between plasma sources have been reported, raising concerns about diagnostic accuracy.


Methods: A total of 64 clinical isolates of S. aureus from human skin, along with the reference strain ATCC 25923, were tested for coagulase activity using human and rabbit plasma. Tube coagulase tests were performed at 4 and 24 hours, and slide coagulase tests were conducted in parallel. Positive results were defined by visible clot formation in the tube tests or clumping within 30 seconds in the slide tests.


Results: With human plasma, 32.8% of isolates were coagulase-positive at 4 hours, increasing to 51.6% after 24 hours. In contrast, only 4.7% of isolates tested positive with rabbit plasma at both 4 and 24 hours. Slide coagulase testing with human plasma demonstrated 100% positivity, whereas the same assay with rabbit plasma yielded only 10.9% positivity.


Conclusion: Coagulase detection in S. aureus is strongly influenced by the plasma source and incubation time. Sole reliance on rabbit plasma may result in significant underdiagnosis, particularly for human-adapted strains. Incorporating multiple plasma sources, extending incubation, and employing confirmatory methods can enhance diagnostic accuracy and prevent misclassification of coagulase-negative S. aureus.

Chi tiết bài viết

Tài liệu tham khảo

1. Tong, S. Y., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. Jr. (2015). Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management. Clinical Microbiology Reviews, 28(3), 603–661.
2. Lowy, F. D. (1998). Staphylococcus aureus infections. New England Journal of Medicine, 339(8), 520–532.
3. Becker, K., Heilmann, C., & Peters, G. (2014). Coagulase-negative staphylococci. Clinical Microbiology Reviews, 27(4), 870–926.
4. McAdow, M., Missiakas, D. M., & Schneewind, O. (2012). Staphylococcus aureus secretes coagulase and von Willebrand factor binding protein to modify the coagulation cascade and establish host infections. Journal of Innate Immunity, 4(2), 141–148.
5. Koneman, E. W., Allen, S. D., Janda, W. M., Schreckenberger, P. C., & Winn, W. C. (2017). Koneman's Color Atlas and Textbook of Diagnostic Microbiology (7th ed.). Lippincott Williams & Wilkins.
6. Kloos, W. E., & Bannerman, T. L. (1999). Staphylococcus and Micrococcus. In Manual of Clinical Microbiology (7th ed., pp. 264–282). ASM Press.
7. Shittu, A. O., & Lin, J. (2006). Antimicrobial susceptibility patterns and characterization of clinical isolates of Staphylococcus aureus in KwaZulu-Natal province, South Africa. BMC Infectious Diseases, 6, 125.
8. Kim, M. N., Pai, C. H., Woo, J. H., Ryu, J. S., & Hiramatsu, K. (2001). Vancomycin-intermediate Staphylococcus aureus in Korea. Journal of Clinical Microbiology, 39(6), 2279–2281.
9. Van Griethuysen, A., Van Loo, I., Van Belkum, A., Vandenbroucke-Grauls, C., Wannet, W., & Van Keulen, P. (2001). Loss of the mecA gene during storage of methicillin-resistant Staphylococcus aureus strains. Journal of Clinical Microbiology, 39(2), 456–460.
10. Duran, N., Ozer, B., Duran, G. G., Onlen, Y., & Demir, C. (2012). Antibiotic resistance genes and susceptibility patterns in staphylococci. Indian Journal of Medical Research, 135(3), 389–396.